Hybrid Fuels Inc. (HRID) Files for Formal Name Change and Announces New Product Line

USA - English

• India - English

FORT LAUDERDALE, Fla., April 23, 2012 /PRNewswire/ -- Hybrid Fuels, Inc. (Pink Sheets:HRID) announced today that it has filed all required information with FINRA to officially change its name to Nouveau Life Pharmaceuticals. The name Nouveau Life Pharmaceuticals more clearly represents the Company's business focus of developing nutraceuticals and all-natural supplements.

In addition to the formal request for a name change, Nouveau Life Pharmaceuticals is excited to announce the development of its new signature line of all-natural supplements to promote healthy living: New Life Naturals(TM). The product line New Life Naturals(TM) will encompass both specialty and routine supplements.

The Company has initiated an aggressive plan to introduce the full line of supplements into the $30 billion U.S. nutraceutical market. Production of its first product is slated to begin this week at an FDA-approved manufacturing facility. The Company's strategic plan calls for a wide range of products to be on the market within the next two months.

About Hybrid Fuels, Inc.
The company was incorporated in the state of Nevada in 1998 as Polo Equities.  It has primarily been a development stage company with management focused on developing innovative business opportunities and further advancing technologies. 

Forward-Looking Statements - This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Hybrid Fuels, Inc. undertakes no obligation to update such statements.

CONTACT:

Nouveau Life Pharmaceuticals, Inc. - 954-903-2993

SOURCE Nouveau Life Pharmaceuticals, Inc.